FRCP FESC Dr J. Chambers MD

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The aims of this study were to investigate possible interactions between EchoGen, a transpulmonary contrast agent in development that vaporizes after injection, and sevoflurane, and to determine the safety of the co-administration of sevoflurane and EchoGen. A phase I, double-blind, randomized, placebo-controlled, three-way crossover study was done in 12(More)
  • 1